Navigation Links
Nano Mask Enters Into Four-Year Distribution Agreement With Saudi Medical Products Distributor
Date:8/25/2011

FISHKILL, N.Y., Aug. 25, 2011 /PRNewswire/ -- Nano Mask, Inc. (NMI) (Pink Sheets: NANM), a healthcare product development and distribution company focused on emergency and critical care as well as infection control markets, has announced that it has entered into a distribution agreement with a Saudi Arabia-based medical products distributor which will represent NMI's product line on an exclusive basis to: The Kingdom of Saudi Arabia, United Arab Emirates, Kuwait, Egypt, Morocco, Oman, Algeria, Qatar, Jordan, Bahrain, Sudan, Yemen Lebanon, Yemen and Tunisia.

In exchange for four years of exclusive rights to distribute NMI's product line in the Territory, the Saudi Arabian medical products distributor, having already delivered to date over $90,000.00 in orders, has agreed to order a minimum of $ 2,300,000 over the next four years. The products that will be marketed and sold in the Territory are NMI's emergency life support and respiratory products (utilizing the company's industry leading patented 2H Filtration Technology), antimicrobial hospital barrier products and NMI's proprietary line of bacteria free enzymatic medical detergents specially formulated for instrument reprocessing.

"This agreement, which covers 15 Middle Eastern countries, represents the first of what we hope will be many international distribution agreements for our products," said Eddie Suydam, President and CEO, NMI.

Mr. Suydam added, "We are currently in negotiations with other medical products distributors, both domestic and international, to sell our products and expect that we will begin to see some meaningful sales from our marketing efforts in the near future."

About Nano Mask, Inc.

NMI is the inventor of 2H Technology, an advanced dual filtration system which is designed to remove infectious bacteria and virus from airflow systems at extremely high levels of efficiency. In addition to the company's advanced filtration materials and products, NMI also markets a line of innovative infection control products which range from proprietary enzymatic instrument reprocessing solutions to innovative antimicrobial textiles in the United States and internationally.

Forward-looking Statement

This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. Specifically, any unforeseen delays in manufacturing and distribution may affect the planned timeline for initiating actual sales of the product. NMI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.

Contact:
For further information:
Ed Suydam  
(914) 760-7857  
eds@nmihealth.com


'/>"/>
SOURCE Nano Mask, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
2. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
5. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
6. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
9. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
10. AcroMetrix Renews Contract With Group Services for Americas Blood Centers
11. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, 2016 ... Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, the ... announced today online at www.diabetesscholars.org by the ... diabetes stand in the way of academic and community ... Foundation,s scholarship program since 2012, and continues to advocate ...
(Date:6/23/2016)... June 23, 2016  Guerbet announced today that it ... Supplier Horizon Award . One of 12 ... recognized for its support of Premier members through exceptional ... excellence, and commitment to lower costs. ... recognition of our outstanding customer service from Premier," says ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):